Form 4: Guardant Health CTO Reports Stock Transaction
Insider Transaction (Form 4)
Darya Chudova, Chief Technology Officer of Guardant Health, Inc., reported multiple transactions in common stock on October 1, 2026.
Summary
- Option exercise/conversion: acquired 1,340 Common Stock on October 1, 2026; holds 71,975 after (Direct).
- Option exercise/conversion: acquired 1,668 Common Stock on October 1, 2026; holds 73,643 after (Direct).
- Option exercise/conversion: acquired 3,324 Common Stock on October 1, 2026; holds 76,967 after (Direct).
- Option exercise/conversion: acquired 1,701 Common Stock on October 1, 2026; holds 78,668 after (Direct).
- Tax/exercise-price withholding: disposed of 4,320 Common Stock at $174.75 ($754,920) on October 1, 2026; holds 74,348 after (Direct).
- Option exercise/conversion: disposed of 1,340 Restricted Stock Units on October 1, 2026 (Direct).
- Option exercise/conversion: disposed of 1,668 Restricted Stock Units on October 1, 2026 (Direct).
- Option exercise/conversion: disposed of 3,324 Restricted Stock Units on October 1, 2026; holds 13,296 after (Direct).
- Option exercise/conversion: disposed of 1,701 Restricted Stock Units on October 1, 2026; holds 10,202 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Darya Chudova — Officer (Chief Technology Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Option exercise/conversion | Common Stock | 1,340 | — | — | 71,975 |
| 2026-10-01 | Option exercise/conversion | Common Stock | 1,668 | — | — | 73,643 |
| 2026-10-01 | Option exercise/conversion | Common Stock | 3,324 | — | — | 76,967 |
| 2026-10-01 | Option exercise/conversion | Common Stock | 1,701 | — | — | 78,668 |
| 2026-10-01 | Tax/exercise-price withholding | Common Stock | 4,320 | $175 | $754.9K | 74,348 |
| 2026-10-01 | Option exercise/conversion | Restricted Stock Units | 1,340 | — | — | 0 |
| 2026-10-01 | Option exercise/conversion | Restricted Stock Units | 1,668 | — | — | 0 |
| 2026-10-01 | Option exercise/conversion | Restricted Stock Units | 3,324 | — | — | 13,296 |
| 2026-10-01 | Option exercise/conversion | Restricted Stock Units | 1,701 | — | — | 10,202 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Option exercise/conversion (1,340 shares) |
| 2026-10-01 | Option exercise/conversion (1,668 shares) |
| 2026-10-01 | Option exercise/conversion (3,324 shares) |
| 2026-10-01 | Option exercise/conversion (1,701 shares) |
| 2026-10-01 | Tax/exercise-price withholding (4,320 shares) |
| 2026-10-01 | Option exercise/conversion (1,340 shares) |
| 2026-10-01 | Option exercise/conversion (1,668 shares) |
| 2026-10-01 | Option exercise/conversion (3,324 shares) |
| 2026-10-01 | Option exercise/conversion (1,701 shares) |
Keywords
insider transaction, Form 4, GH, Guardant Health, Inc., neutral, Darya Chudova
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.